Rugo HS, Umanzor GA, Barrios FJ, Vasallo RH, et al. Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer. J Clin Oncol 2022 Jul 20:JCO2102953. doi: 10.1200/JCO.21.02953.
PMID: 35858154